News
IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...
In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.
Systlmmune and BMS’ ACD treats patients with previously treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer.
Developed by Daiichi Sankyo and Merck, it treats patients with Pretreated Extensive-Stage Small Cell Lung Cancer.
Anocca AB ( Anocca ), a clinical-stage T-cell immunotherapy company, raised SEK ~440 million (USD ~46 million) in financing. Mellby Gård led the financing with strong support from AMF, Ramsbury, and ...
Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the ...
AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...
Bayer and Kumquat Biosciences have entered an exclusive global license and collaboration to develop and commercialize Kumquat ...
Envirotainer, a provider of secure cold chain solutions for temperature-sensitive pharmaceuticals, has invested in Swiss ...
Oxford BioDynamics (OBD) has partnered with Google Cloud to expand the capabilities of its 3D genomic biomarker technology.
Platform and product releases span OPUS, MINT, POET, and SPI.
Sartorius supports commercialization and joint development of solutions based on Nanotein’s NanoSpark platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results